Alvotech

1.56
-0.31 (-16.58%)
At close: Mar 28, 2025, 3:39 PM
1.56
0.00%
After-hours: Mar 28, 2025, 04:00 PM EDT

Company Description

Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets.

The company is based in Iceland.

Alvotech
Alvotech logo
Country IS
IPO Date Jun 16, 2022
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 999
CEO Robert Wessman

Contact Details

Address:
Saemundargata 15-19
Reykjavik,
IS
Website https://www.alvotech.com

Stock Details

Ticker Symbol ALVOW
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001898416
CUSIP Number L01800116
ISIN Number LU2458333858
Employer ID 98-1629342
SIC Code 2836

Key Executives

Name Position
Robert Wessman Chief Executive Officer, Founder & Executive Chairman
Faysal Kalmoua Chief Operating Officer & Director
Joel Morales Chief Financial Officer
Anil Okay Chief Commercial Officer
Benedikt Stefansson Vice President of Investor Relations and Global Communications
Giedrius Zunda Chief Technical Officer
Jenny Sif Steingrimsdottir Vice President of People & Culture
Joseph E. McClellan Chief Scientific Officer
Ming Li Chief Strategy Officer
Tanya Zharov General Counsel

Latest SEC Filings

Date Type Title
Mar 27, 2025 6-K Filing
Mar 27, 2025 20-F Filing
Mar 27, 2025 6-K Filing
Mar 26, 2025 6-K Filing
Mar 20, 2025 6-K Filing
Mar 18, 2025 6-K Filing
Feb 24, 2025 6-K Filing
Feb 18, 2025 6-K Filing
Jan 27, 2025 6-K Filing
Dec 23, 2024 6-K Filing